FDA warns of serious allergic reactions with some multiple sclerosis drugs
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
FDA warns of serious allergic reactions with multiple sclerosis drugs
The U.S. Food and Drug Administration on Wednesday warned about the risk of a rare but serious allergic reaction with the use ...
healthday4h
Multiple Sclerosis May Worsen With Menopause Transition
The menopausal transition may represent an inflection point for worsening of multiple sclerosis (MS) in women, accordi ...
Medscape9h
Stop Disease-Modifying Therapy in Stable MS: Yes or No?
MS patients who achieve long-term stable disease on disease-modifying therapy may want to stop their medication for varying ...
Multiple sclerosis linked to higher risk of mental illness during and after pregnancy
People with multiple sclerosis (MS) face a significantly higher risk of perinatal mental illness compared to those with other ...
The American Journal of Managed Care1d
FDA Warns of Severe Allergic Reactions With Certain Multiple Sclerosis Drugs
The FDA issued a boxed warning for anaphylaxis risk linked to Glatiramer acetate and Glatopa, used in MS treatment.
GlobalData on MSN1d
FDA adds boxed warning to multiple sclerosis drugs after anaphylaxis cases
Teva Pharmaceutical’s Copaxone was approved by the FDA in 1996 to treat relapsing forms of MS, an autoimmune disorder that ...
New Study Links Multiple Sclerosis to Increased Mental Health Risks During and After Pregnancy
A new study reveals that people with multiple sclerosis (MS) experience significantly higher rates of mental illness during ...
FiercePharma1d
Teva's multiple sclerosis stalwart Copaxone gets FDA boxed warning for anaphylaxis risk
After years of legal wrangling surrounding Teva’s Copaxone, the latest hit to the lucrative multiple sclerosis drug comes in ...
Healio2d
FDA issues anaphylaxis warning on multiple sclerosis treatment
The FDA has advised health care professionals and patients with multiple sclerosis that treatment with glatiramer acetate is ...
Science Daily7h
Researchers identify key protein to potentially halt autoimmune diseases and allergies
Researchers identified a key protein as a potential therapeutic target for stopping the body's immune system from mistakenly attacking itself, offering new hope for treating autoimmune diseases and ...